Stocks
Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 2.17 | 0.94 | 4.39 | -0.27 | -2.93 | -2.83 | ||
| Changes by years, y/y, % | +18% | -57% | +367% | -106% | +970% | |||
Alnylam Pharmaceuticals. Debt/EBITDA
Alnylam Pharmaceuticals. Debt/EBITDA, changes, %
Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | -0.59 | 0.69 | -7.59 | -3.45 | -2.83 | -2.83 | ||
| Changes by years, y/y, % | -73% | +3% | -1 939% | +1 162% | +380% | |||
| Changes by quarters, q/q, % | +116% | -217% | -1 201% | -55% | -18% | |||
